Search Results 251-260 of 6138 for albumin

  1. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    * Albumin \> 3.0 g/dL * Females of childbearing potential must have a negative pregnancy test within 72 hours prior to registration. If the urine test is ...

  2. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    albumin ≥ 3.0 g/dL;; international normalized ratio (INR) and partial thromboplastin time (PTT);; ≤ 1.5 x ULN;; amylase and lipase ≤ 1.5 x ULN. No evidence ...

  3. Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    Albumin > 3.0 g/dL (3.0 g/dL is equivalent to 30 g/L). HIV-infected patients who are healthy and have a low risk of AIDS-related outcomes are included in ...

  4. A Study to Evaluate Noninvasive Ultrasound Elastography of Kidney and Lung in Assessment of Volume Status in ICU Patients - Mayo Clinic

    The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients with critical ...

  5. Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) - Mayo Clinic

    Another kidney biopsy will not be required as part of the study. Candidates must have failed or be intolerant of prior therapy for their kidney disease. The ...

  6. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    Serum albumin < 3.5 g/dL;; Platelet count < 100 × 103/μL;; International normalized ratio (INR) > 1.4, unless due to therapeutic anticoagulation;; Fasting ...

  7. Publications - Michael A. Mao, M.D. - Mayo Clinic

    Impacts of admission serum albumin levels on short-term and long-term mortality in hospitalized patients. QJM. 2020 Jun 1; 113 (6):393-398. View PubMed ...

  8. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

    Platelet count ≥ 100,000/mm^3 (obtained ≤ 15 days prior to registration). Albumin ≥ 2.5 mg/dL (obtained ≤ 15 days prior to registration); Total bilirubin ...

  9. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

    Albumin ≥ 2.8 g/dL. Adequate coagulation function defined as prothrombin time or international normalized ratio ≤ 1.5 × ULN unless the participant is ...

  10. Melanoma Clinical Trials - Mayo Clinic Research

    Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...